Welcome to the e-CCO Library Archive!
Can we predict myelotoxicity development during thiopurine therapy for inflammatory bowel disease?
A. Kharitonov1, O. Shchukina1, S. Lapin2, T. Bulgakova2, A. Baranovsky1, 1North-Western state medical university named after I.I.Mechnikov, Chair of gastroenterology and dietology, Saint-Petersburg, Russian Federation, 2First Saint-Petersburg state medical university named after I.P. Pavlov, Laboratory of autoimmune diseases, Saint-Petersburg, Russian Federation
P. Ellul1, C. Saliba2, N. Azzopardi3, D. Grech Margeurat3, G. Laferla2, G. Grech2, 1Mater Dei Hospital, Msida, Malta, 2University of Malta, Malta, 3Mater Dei Hospital, Malta
Long-term colectomy rates in patients with Ulcerative Colitis treated with Infliximab: A single Canadian tertiary care centre's experience
M. Cooray*1, A. Meadley2, S. Halder3
1McMaster University, Gastroenterology, Burlington, Canada, 2McMaster University, Department of Internal Medicine, Hamilton, Canada, 3McMaster University, Gastroenterology, Hamilton, Canada
Crohn's Disease (CD) in the elderly – an IG-IBD study
A. Viola1, L. Cantoro2, R. Monterubbianesi2, F. Castiglione3, M. Principi4, I. Frankovic5, D. Pugliese6, F. Callela7, S. Saibeni8, A. Aratri9, S. Orlando10, M. Cappello11, G. Costantino12, N. Mannetti13, G. Mocci14, L. Samperi15, G. Inserra15, A.C. Privitera16, F. Caprioli17, V. Annese18, C. Papi19, A. Armuzzi20, R. D'Incà21, A. Kohn2, F. Manguso22, W. Fries1, 1University of Messina, Dept. of Clinical and Experimental Medicine, Messina, Italy, 2San Camillo-Forlanini, UOC Gasteroenterologia, Roma, Italy, 3Università “Federico II” di Napoli, Gastroenterologia, Napoli, Italy, 4University of Bari, Gastroenterology Section (D.E.T.O.), Bari, Italy, 5Gastroenterologia, Departimento di Medicina, Padova, Italy, 6Complesso Integrato Columbus, Catholic University, IBD UNIT, Roma, Italy, 7Ospedale San Giuseppe, UOC Gastroenterologia, Empoli (FI), Italy, 8AO Fatebenefratelli e Oftalmico, UOC di Medicina Interna ed Epatologia, Milano, Italy, 9ACO San Filippo Neri, UOC Gastroenterologia ed Epatologia, Roma, Italy, 10Fondazione IRCCS Cá Grande Ospedale Policlinico di Milano, UO Gastroenterologia, Milano, Italy, 11A.O.U. Policlinico, UOC Gastroenterologia ed Epatologia, Palermo, Italy, 12Università di Messina, Dept. of Clinical and Experimental Medicine, Messina, Italy, 13Careggi, University Hospital, Gastroenterology Unit, Florence, Italy, 14Ospedale Brodzu, UOC di Gastroenterologia, Cagliari, Italy, 15University of Catania, Dip. di Scienze Mediche e Pediatriche, UO Medicina Interna, Catania, Italy, 16A.O. per l'Emergenza Cannizzaro, IBD UNIT, Catania, Italy, 17Fondazione IRCCS Cá Grande Ospedale Policlinico di Milano, Dipartimento di Fisiopatologia medico-chirurgica e dei trapianti, Milano, Italy, 18Careggi, University Hospital, Gastroenterology Unit, Firenze, Italy, 19AOU Policlinico Federico II of Naples, Gastroenterology, Naples, Italy, 20Catholic University, Rome, Complesso Integrato Columbus, IBD UNIT, Roma, Italy, 21Dip. di Medicina, OC Padova, Gastroenterologia, Padova, Italy, 22AORN A. Cardarelli, Napoli, UOC of Gastroenterology, Napoli, Italy
I. Nathan1, K.C. Fragkos1, A. Forbes1, 1University College London, Centre for Gastroenterology and Nutrition, London, United Kingdom
Care of women with gastrointestinal conditions during family planning and pregnancy
M. Clowse*1, M. Druzin2, M. Khamashta3, D. Pushparajah4, S. Horst5
1Duke University Medical Center, Duke University, Durham, United States, 2School of Medicine, Stanford University, Stanford, California, United States, 3Lupus Research Unit, The Rayne Institute, St Thomas Hospital, London, United Kingdom, 4UCB Pharma, Patient Affairs, Brussels, Belgium, 5Vanderbilt University, Medical Center, Nashville, United States
Combined immunosuppression, corticoids and menopause have significant influence on bone mineral density of IBD patients. A prospective study
A. Krajcovicova, T. Hlavaty, Z. Killinger, E. Miznerova, J. Toth, D. Cierny, T. Koller, J. Letkovsky, Z. Zelinkova, M. Huorka, J. Payer, University Hospital Bratislava, 5th Department of Internal Medicine, Bratislava, Slovakia
R. Lynch1, A. Protheroe2, M. Roughton2, I. Arnott1, UK IBD Audit Steering Group2, 1NHS Lothian, Gastroenterology, Edinburgh, United Kingdom, 2RCP, CEEU, London, United Kingdom
Assessment of Lactose Intolerance in Ulcerative Colitis Patients on Remission
E. AHISHALI*1, E.E. AKKUS2, C. DOLAPCIOGLU1, M. SAYINER2, T. ARSLAN2, R. YILMAZ3, A. KURAL1, R. DABAK2
1Dr. Lutfi Kirdar Kartal Education and Research Hospital, Department of Gastroenterology, ISTANBUL, Turkey, 2Dr. Lutfi Kirdar Kartal Education and Research Hospital, Department of Family Medicine, ISTANBUL, Turkey, 3Dr. Lutfi Kirdar Kartal Education and Research Hospital, Department of Endocrinology, ISTANBUL, Turkey
Bone mineral density measurement using dual energy X-ray in inflammatory bowel disease patients – Are we screening our patients for osteoporosis?
F.A. Rana1, D. Tate2, M.M. Shaikh3, J. Bowles1, 1Great Western Hospital NHS Foundation Trust, Gastroenterology, Swindon, United Kingdom, 2Royal United Hospital NHS Trust, Gastroenterology, Bath, United Kingdom, 3James Cook University Hospital, Rheumatology, Middlesbrough, United Kingdom
U. Chauhan1, U. Dutta2, D. Armstrong2, J. Marshall2, F. Tse2, E. Greenwald2, T. Xenodemetropoulos2, S. Halder2, 1McMaster University Medical Centre, Digestive Disease Speciality Adult Service, Hamilton ON, Canada, 2McMaster University, Division of Gastroenterology, Hamilton ON, Canada
Factors associated with drug non-adherence in an Indian IBD patient cohort: It's not always the cost
R. Banerjee1, U. Basavaraju*2, B. Adigopula1, V. Nagalaxmi1, N. Reddy1
1Asian Institute of Gastroenterology, Inflammatory Bowel Disease, Hyderabad, India, 2Aberdeen Royal Infirmary, Nhs Grampian, Digestive Disorders, Aberdeen, United Kingdom
Bolus administration of steroid therapy is more favourable than the conventional use in preventing decrease of bone density and the increase of body fat percentage in patients with inflammatory bowel disease
K. Farkas1, A. Bálint1, Z. Valkusz1, Z. Szepes1, F. Nagy1, M. Szücs2, R. Bor1, T. Wittmann1, T. Molnár1, 1University of Szeged, First Department of Medicine, Szeged, Hungary, 2University of Szeged, Department of Medical Physics and Informatics, Szeged, Hungary
P.G. Kotze1, J. Ludvig2, F.V. Teixeira3, H. Kleinubing Jr.4, E.F. Malluta5, E.F. Miranda1, M. Hardt1, M. Olandoski6, L.M.S. Kotze7, 1Catholic University of Parana, Colorectal Surgery Unit, Curitiba – PR, Brazil, 2Esadi, Gastroenterology unit, Blumenau – SC, Brazil, 3Gastrosaude, Colorectal Surgery Unit, Marilia – SP, Brazil, 4Univille, Colorectal Surgery unit, Joinville – SC, Brazil, 5Univali, Gastroenterology unit, Itajai – SC, Brazil, 6Catholic University of Parana, Statistics, Curitiba – PR, Brazil, 7Catholic University of Parana, Gastroenterology unit, Curitiba – PR, Brazil
An Open-label Prospective Randomized Multicentre Study of Daily Granulocyte and Monocyte Adsorptive Apheresis as Compared with Intensive Treatment in Patients with Active Ulcerative Colitis
K. Mizukami*, A. Sonoda, T. Okimoto, M. Kodama, K. Murakami
Oita university, Gastroenterology, Oita, Japan
Biological therapy in children and adolescents: infliximab and adalimumab, a comparison of their side effects
F. Calzolari, F. Vincenzi, F. Fornaroli, B. Bizzarri, A. Ghiselli, C. Calzolari, A. Salerno, G. Nervi, G.L. de' Angelis, University Hospital of Parma, Gastroenterology and Digestive Endoscopy Unit, Parma, Italy
M. Sanges1, M. Miniero1, M.G. Ceriello1, A. Piacente1, L. Florio1, D. Trio1, O. Donatore1, D. Mattera1, R. Sollazzo1, A. D'Arienzo1, 1Federico II University of Naples, Gastroenterology Unit, Department of Clinical and Experimental Medicine, Naples, Italy
Impact of mucosal healing on the clinical course in a cohort of paediatric patients affected by Crohn's Disease
F. Nuti, F. Viola, M. Aloi, F. Civitelli, S. Oliva, S. Cucchiara*
Sapienza, Rome, Pediatric Gastroenterology and Liver Unit, Rome, Italy
Biological agents for moderately-to-severely active ulcerative colitis in adults: a network meta-analysis of randomized controlled trials
S. Danese1, G. Fiorino1, L. Peyrin-Biroulet2, E. Lucenteforte3, G. Virgili4, L. Moja5,6, S. Bonovas7, 1Humanitas Research Hospital, IBD Center, Rozzano, Milan, Italy, 2Nancy University Hospital, Université de Lorraine, Gastroenterology and Hepatology, Vandoeuvre-les-Nancy, France, 3University of Florence, Department of Neurosciences, Psychology, Drug Research and Child Health, Florence, Italy, 4University of Florence, Department of Specialised Surgical Sciences, Florence, Italy, 5IRCCS Galeazzi Orthopedic Institute, Unit of Clinical Epidemiology, Milan, Italy, 6University of Milan, Department of Biomedical Sciences for Health, Milan, Italy, 7IRCCS Mario Negri Institute for Pharmacological Research, Laboratory of Drug Regulatory Policies, Milan, Italy
H.-L. Ching1, F. Chariah1, G. Lipman1, M. Train2, S. Mann1, 1Barnet and Chase Farm Hospitals NHS Trust, Gastroenterology, London, United Kingdom, 2Barnet and Chase Farm Hospitals NHS Trust, Radiology, London, United Kingdom